RxDoctor Payments Data

Karey Davis, PA

Medical · New Castle, INNPI 1508082066

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $28,575 of the $45,202 with a category attached, or 63.2%. Boston Scientific accounts for 92.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $23,647 and has fallen 51.5% since, to $11,458 in 2025. Among medical clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,202in general payments, 2019–2025

Across 297 payments — averaging $152.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$42K
  • Abbott$2K
  • Medtronic$192
  • MML US, Inc.$191
  • Pacira Therapeutics, Inc.$156
  • Novo Nordisk$102
  • plus $523 from 12 others

What the payments were for

  • Speaking & faculty fees$28,57563%
  • Travel & lodging$9,58921%
  • Food & beverage$7,03816%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,202 in reported general payments places this provider in the 95th percentile of 273 medical providers in Indiana.

See all medical providers in Indiana

Medicare billing

Part B allowed, 2024
$1,305
Medicare patients
11
Services billed
37

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen71$1,611
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$491
Gabapentin26$423
Oxycodone Hcl16$171
Tizanidine Hcl13$104
Cyclobenzaprine Hcl12$103
Meloxicam11$39

Paid to pharmacies, not to this prescriber.

Other medical in New Castle

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →